Keyphrases
Human Cytomegalovirus
95%
Cytomegalovirus
94%
Cytomegalovirus Infection
89%
Congenital Cytomegalovirus
34%
Cytomegalovirus Vaccine
31%
Guinea pig
26%
Virus
23%
Sudden Sensorineural Hearing Loss (SSNHL)
20%
Guinea pig Model
20%
Congenital Infection
18%
Vaccine Development
16%
Guinea pig CMV
15%
Glycoprotein B
15%
Fetus
13%
Breast Milk
12%
COVID-19
12%
Minnesota
12%
Pediatric
12%
Hearing Impairment
12%
Vaccination
11%
Cytomegalovirus Disease
11%
Bacterial Artificial Chromosome
11%
Antiretroviral Therapy
11%
COVID-19 Pandemic
10%
P-p65
9%
Pregnancy Outcome
9%
Cytomegalovirus Viremia
9%
Viral Load
9%
Pentameric Complex
9%
Quantitative PCR
8%
Viremia
8%
Herpesvirus
8%
Congenital CMV Infection
8%
CMV Infection
8%
Clinical Trials
7%
Dried Blood Spots
7%
Vaccine Strategy
7%
Upstream Open Reading Frame (uORF)
7%
Placenta
7%
Congenital Cytomegalovirus Disease
7%
Pregnant Women
7%
United States
7%
Immunization
7%
DNAemia
7%
Newborn Screening
7%
Premature Infant
6%
Developing World
6%
UL83
6%
Immune Response
6%
Congenital Transmission
6%
Congenital CMV
6%
Pupal Mortality
5%
Ganciclovir
5%
Public Health Priority
5%
Neonate
5%
Viral
5%
Salivary Gland
5%
Tropism
5%
Epidemiology
5%
Human CMV
5%
Newborn Infant
5%
Fibroblasts
5%
Epithelial Cells
5%
Maternal Immunity
5%
Molecular Characterization
5%
Medicine and Dentistry
Cytomegalovirus
97%
Infection
43%
Cytomegalovirus Infection
40%
Congenital Cytomegalovirus Infection
39%
Disease
30%
Neonatal Infant
29%
Human Cytomegalovirus
20%
Pediatrics
17%
Sensorineural Hearing Loss
17%
Hearing Impairment
15%
Cytomegalovirus Vaccine
13%
Dried Blood Spot
12%
COVID-19
12%
Viremia
12%
Human Milk
11%
Public Health
9%
Antiviral Therapy
9%
Antivirus Agent
8%
Human Immunodeficiency Virus
8%
Congenital Infection
8%
Newborn Screening
7%
Real Time Polymerase Chain Reaction
7%
Vaccine Development
7%
Pathogen
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Prematurity
6%
Awareness
5%
Clinical Trial
5%
Sequela
5%
Virus Infection
5%
Auditory Screening
5%
Neonates
5%
Transplantation
5%
Immune Response
5%
Polymerase Chain Reaction
5%
Immunology and Microbiology
Cytomegalovirus
100%
Guinea Pig
64%
Vaccine Efficacy
45%
Cytomegalovirus Infection
37%
Human Cytomegalovirus
36%
Glycoprotein
22%
Cytomegalovirus Vaccine
20%
Herpesviridae
12%
Guinea Pig Model
12%
Bacterial Artificial Chromosome
10%
Viremia
10%
Vaccination Policy
9%
Immune Response
7%
Monospecific Antibody
6%
Viral Disease
6%
Fibroblast
6%
Human Immunodeficiency Virus
6%
Viral Load
6%
Open Reading Frame
5%
Adoptive Immunity
5%
Infectious Agent
5%
Viral Replication
5%
Plasmid
5%
Placenta
5%